DIA, in partnership with the Middle East Regulatory Network (MERN), will host the 9th DIA Middle East Regulatory Conference (MERC) from 1-2 February 2011 in Amman, Jordan.
MERC provides an opportunity for key stakeholders active in the region, including representatives from ministries of health and local and multinational pharmaceutical companies, to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies. Session topics include:
• Local Regulatory Authority Views and Key Issue
• Global Regulatory Environment and Opportunities for the Middle East
• Pre- Post Marketing Safety and Pharmacovigilance
• Falsified Medicines
• Role of Research and Development in Patient Access to New Medicines
• Market Access – Harmonisation of Documentation
• Changing Regulatory Environment
“Since its inception 13 years ago, the Middle East Regulatory Conference has grown to become an important forum for the discussion of matters related to the provision of healthcare in the region,” explains Programme Chairperson Professor Trevor M. Jones, CBE, WHO Commissioner, CIPIH, UK. “MERC brings together all major stakeholders from across the region and Europe to discuss the global regulatory environment and better patient access to new medicines.”
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.